Lupin Ltd (LUPN)

1,242.05 -16.65 (-1.32%)
Delayed Data INR Disclaimer

Lupin Ltd Company Profile

Equity Type
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in India and internationally. It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women’s health, and anti-tuberculosis. The company is also involved in the provision of biosimilars; over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Contact Information
Off. Western Expressway Highway Santacruz (East) Mumbai,400055 India
91 22 6640 2323
91 22 2652 8806
Top Executives
Manju Deshbandhu Gupta 77 2017 Non-Executive Chairman of the Board
Vinita D. Gupta 53 2003 CEO & Executive Director
Jean-Luc Belingard 74 2015 Independent Non-Executive Director
Punita Kumar-Sinha 60 2020 Independent Director
Kanwar Bir Singh Anand 67 2020 Independent Director
Mark D. McDade 68 2021 Independent Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.